Syngenta Corn Seed Lawsuit Results in $218 Million Verdict for Farmers

In the first bellwether trial for lawsuits over Syngenta corn seed, a jury awarded almost $218 million to farmers for damages caused by the sale of a genetically modified product, known as Viptera, which resulted in a massive drop in the value of U.S. corn several years ago.

The case was a class action, representing 7,000 farmers from Kansas who will share the award, after a federal jury determined that Syngenta caused significant financial damages by marketing the GMO corn seed before it was approved for import by China, which comprises a large portion of the corn market.

The trial is the first for about 60,000 Syngenta corn seed lawsuits filed by farmers and agri-businesses nationwide, many of whom did not grow Viptera, but had their corn rejected by China because of cross-pollination concerns.

While China eventually approved the genetic trait produced by Syngenta’s Agisure Viptera and Agisure Duracade corn seeds, also known as MIR162, farmers and agricultural companies maintain that they have suffered significant economic harm due to drops in corn prices when China rejected any imports with traces of MIR162, which widely contaminated the entire U.S. corn supply.

Farmers and others in the industry estimate that $5 billion in damages have been caused by the GMO corn seed, since corn products grown at many different farms are commonly co-mingling, and Syngenta also recommended that Agisure Viptera and Duracade seed be grown next to other corn, causing cross-pollination.

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided to centalize all Syngenta GMO corn lawsuits before Judge Lungstrum for pretrial proceedings in the District of Kansas.

Following the coordinated pretrial proceedings, if Syngenta corn seed settlements are not reached to resolve the litigation, individual cases may be remanded back to the U.S. District Courts where they were originally filed for separate trials across the country.

Syngenta has indicated it plans to appeal this first verdict, but faces a second bellwether trial that is slated to begin next month in Minnesota.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges
Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges (Posted 2 days ago)

A Wegovy gastroparesis lawsuit filed by a Pennsylvania couple accuses the manufacturer, Novo Nordisk, of failing to provide adequate warnings about the true risks of the injectable weight loss drug.

Lawyers
Lawyers "Optimistic" Suboxone Tolling Agreement Will Be Reached For Tooth Decay Lawsuits (Posted 3 days ago)

Plaintiffs and defendants involved in Suboxone tooth decay lawsuits say they are close to a deal that would allow the filing of federal complaints after some state statue of limitation laws would have disqualified plaintiffs from filing.

Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users
Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users (Posted 4 days ago)

New Jersey man indicates he has been left with permanent hearing impairment from Tepezza, alleging that Horizon Therapeutics failed to instruct doctors about the importance of conducting hearing tests on patients using the thyroid eye disease drug.